Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | unknown | — | 10,000 | Tongji HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT00108745 | Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | unknown | Phase 3 | 1,157 | GOG FoundationNETWORK | 1 | Sep 30, 2021 |
| NCT00954174 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | unknown | Phase 3 | 637 | GOG FoundationNETWORK | 2 | Sep 30, 2021 | clinicaltrials |
| NCT02065687 | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer | unknown | Phase 2 / Phase 3 | 469 | Gynecologic Oncology GroupNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT02388698 | FDG-PET and Circulating HPV in Patients With Cervical Cancer | unknown | N/A | 84 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04731038 | Combination Therapy for First Line Treatment of Advanced Cervical Cancer | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT04935333 | Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy(MYOSARCII) | unknown | — | 600 | IgenomixINDUSTRY | 1 | Sep 10, 2021 | clinicaltrials |
| NCT00980759 | Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer | unknown | N/A | 312 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 8, 2021 | clinicaltrials |
| NCT05026073 | Vibrational Spectroscopy for Endometrial Cancer Diagnosis(SPEED) | unknown | — | 150 | Nottingham University Hospitals NHS TrustOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04238988 | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer(MITO CERV 3) | unknown | Phase 2 | 45 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT05013268 | Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma(TiTanec) | unknown | Phase 1 | 15 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05018195 | Adipocytokines in Endometrial Cancer(ACEmCa) | unknown | N/A | 200 | National Taiwan University HospitalOTHER | 0 | Aug 24, 2021 | clinicaltrials |
| NCT04974827 | A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | unknown | Phase 2 | 46 | Hunan Cancer HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04974424 | Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV | unknown | — | 20,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04973904 | Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer | unknown | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT04519593 | ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma | unknown | N/A | 120 | Mother and Child Clinic Saint-PetersburgOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04961775 | A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer | unknown | — | 277 | Chinese PLA General HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04958278 | Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve(ENDO-GREEN) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04665544 | Tracers for Endometrial Cancer Sentinel Node Labeling(TESLA-1) | unknown | N/A | 83 | University Medical Centre MariborOTHER | 3 | Jun 14, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT04918628 | Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer(CRTCP) | unknown | Phase 2 | 50 | Taizhou HospitalOTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | unknown | Phase 2 | 90 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04395612 | Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer(CQGOG0101) | unknown | Phase 2 | 38 | Chongqing University Cancer HospitalOTHER | 1 | May 21, 2021 | clinicaltrials |
| NCT03676959 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer | unknown | Phase 1 | 101 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 13, 2021 | clinicaltrials |
| NCT04884906 | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT03852823 | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours | unknown | Phase 1 | 192 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04868097 | Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2 | unknown | N/A | 52 | Kaplan Medical CenterOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04819685 | Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury | unknown | Phase 4 | 520 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer(EMBRACE) | unknown | — | 1,416 | Medical University of ViennaOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | unknown | — | 3,000 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04461574 | Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer | unknown | N/A | 160 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04800978 | Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 0 | Mar 16, 2021 | clinicaltrials |
| NCT04789941 | How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix | unknown | Phase 2 | 50 | Assiut UniversityOTHER | 0 | Mar 10, 2021 | clinicaltrials |
| NCT04787159 | Endometrial Cancer International Database(ECID) | unknown | — | 1,000 | Assiut UniversityOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT04783649 | Clinical Validation of Cervical Cancer Screening Methods | unknown | — | 2,500 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04400942 | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | unknown | — | 600 | Ospedale Policlinico San MartinoOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT03808857 | A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive | unknown | Phase 2 | 80 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04748978 | OPPIuM Technique and Myolysis With Diode Laser Dwls(Myolysis) | unknown | N/A | 35 | University of CagliariOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT03207061 | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? | unknown | N/A | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03543215 | Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | unknown | — | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT04251676 | Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis | unknown | — | 200 | National Taiwan University HospitalOTHER | 0 | Feb 11, 2021 | clinicaltrials |
| NCT04508686 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04577950 | A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer(SENNAN) | unknown | N/A | 120 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04637022 | 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial | unknown | — | 50 | Catholic University of the Sacred HeartOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT02624531 | Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)(SYSUGO-005) | unknown | N/A | 60 | Sun Yat-sen UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT00501761 | Physical Activity After Endometrial Cancer | unknown | — | 326 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04664244 | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma | unknown | Phase 2 | 43 | Lei LiOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04678791 | Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma | unknown | N/A | 286 | Peking University Third HospitalOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04651738 | Cell-free DNA Methylation for Endometrial Cancer | unknown | N/A | 400 | Lei LiOTHER | 1 | Dec 21, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Oct 7, 2021source: clinicaltrials